One-time gene therapy injection could provide HIV treatment that may last a lifetime
July 08, 2022
OHSU researcher receives $5 million grant to study long-term suppression of human immunodeficiency virus in nonhuman primates.
Booster dose and breakthrough infection provide similar COVID ‘super immunity,’ study finds
April 20, 2022
OHSU laboratory research compares immune response to live virus variants, including omicron.
March 10 forecast continues to show virus receding in Oregon
March 10, 2022
COVID-19 statewide forecasts will be posted online on a biweekly basis
OHSU research is latest to characterize potential end of COVID-19 pandemic
February 28, 2022
Lab results suggest durable immunity against variants.
New study suggests two paths toward ‘super immunity’ to COVID-19
January 25, 2022
OHSU laboratory research compares routes to immunity involving vaccination.
OHSU investigators awarded $3 million for innovative, promising research
January 24, 2022
New funds for leading-edge research on malaria vaccines, emerging viral diseases, gun violence prevention, gene regulatory control.
Breakthrough infections generate ‘super immunity’ to COVID-19, study suggests
December 16, 2021
COVID-19 vaccination provides a foundation of protection that’s enhanced by breakthrough infection; ‘the key is to get vaccinated.'
Children account for high proportion of Oregonians susceptible to COVID-19 infection
November 04, 2021
Nov. 4 OHSU forecast emphasizes benefits of vaccination for newly eligible kids age 5 to 11.
OHSU Science Café series to explore COVID-19, reproductive health
October 18, 2021
Virtual science talks organized by OHSU’s Oregon National Primate Research Center.
COVID-19 booster shots approved
September 27, 2021
COVID-19 booster shots recommended for all adults who received Johnson & Johnson vaccination, many adults who received Moderna, Pfizer vaccinations.
